Kurtzke JFEpidemiology of cerebrovascular disease. In: McDowell FH, Caplan LR (eds) Cerebrovascular survey report 1985. Bethesda: National Institutes of Health, 1985; 1-34.
2.
American Heart Association.1989 Stroke facts. Dallas: American Heart Association, 1988.
3.
Alberts MJ, Bertels C., Dawson DVAn analysis of time of presentation after stroke. JAMA1990;263:65-68.
4.
Sivenius J., Pyorala K., Heinonen OP, Salonen JT, Riekkinen P.The significance of intensity of rehabilitation of stroke: a controlled trial . Stroke1985;16:928-931.
5.
Dignan MB, Howard G., Toole JF, Becker C., McLeroy KHEvaluation of the North Carolina Stroke Care Program. Stroke1986;17:382-386.
6.
Feeney DM, Sutton RLPharmacotherapy for recovery of function after brain injury. CRC Crit Rev Neurobiol1987;3: 135-197.
7.
Goldstein LB , Davis JNPhysician prescribing patterns after ischemic stroke. Neurology1988;38:1806-1809.
8.
Welch Kma, Barkley GLBiochemistry and pharmacology of cerebral ischemia. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds) Stroke. New York: Churchill Livingstone, 1986;75-90.
9.
Choi DWCalcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. TINS1988;11:465-469.
10.
Fujisawa A. , Matsumoto M., Matsuyama T., et al. The effect of the calcium antagonist nimodipine on the gerbil model of experimental cerebral ischemia. Stroke1986;17:748-752.
11.
Germano I., Bartkowski H., Nishimura M., Cassel B., Pitts L.The effects of nimodipine in acute experimental cerebral ischemia in the rat . Stroke1986;17:144.
12.
Vibulsresth S., Dietrich WD, Busto R., Ginsberg MDFailure of nimodipine to prevent ischemic neuronal damage in rats. Stroke1987;18:210-216.
13.
De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen Paj.Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke1989;20:1383-1390.
14.
Latchaw JP, Capraro J., Moufarrij N., et al. The effects of verapamil, thromboxane synthetase inhibitor, chlorpromazine, and propanolol in acute focal cerebral ischemia. J Cereb Blood Flow Metab1983;3:S367-S368.
15.
MacMillan V.Effects of promethazine on the energy metabolism of normoxic and hypoxic rat brain. Stroke1982; 13:464-469.
16.
Gelmers HJ, Gorter K, DeWeerdt CJ, Wiezer HJA. A controlled trial of nimodipine in acute ischemic stroke. NEJM1988;318:203-207.
17.
MohrJP, Dilanni M., Muschett JL, Riccio RV, GH Bessalaar Associates, The Nimodipine Study Group. Nimodipine in acute ischemic stroke. Ann Neurol1989;26:124 (abstr.).
Martz D., Rayos G., Schielke GP, Betz ALAllopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke1989;20:488-494.
21.
Itoh T., Kawakami M., Yamauchi Y., Shimizu S., Nakamura M.Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Stroke1986;17:1284-1286.
22.
Yamamoto M. , Shima T., Uozumi T., Sogabe T., Yamada K., Kawasaki T.A possible role of lipid peroxidation in cellular damages caused by cerebral ischemia and the protective effect of alpha tocopherol administration. Stroke1983; 14: 977-982.
23.
Bazan NG Jr.Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta1970 ;218:1-10.
24.
Yatsu FM, Moss SABrain lipid changes following hypoxia. Stroke1971;2:587-593.
25.
Kakihana M. , Fukuda N., Suno M.Effects of CDP-Choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke1988;19:217-222.
26.
Tazaki Y., Sakai F., Otomo E.Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo controlled study. Stroke1988;19:211-216.
27.
Katzman R., Clasen R., Klatzo I., Meyer JS, Pappius HM, Waltz AGReport of Joint Committee for Stroke Resources. IV. Brain edema in stroke . Stroke1977;8:512-540.
28.
Ito U., Ohno K., Suganuma Y., Suzuki K., Inaba Y.Effect of steroid on ischemic brain edema. Stroke1980;11: 166-172.
29.
BremerAM, Yamada K., West CRIschemic cerebral edema in primates: effects of acetazolamide, phenytoin, sorbitol, dexamethasone, and methylprednisolone on brain waterand electrolytes . Neurosurgery1980;6:149-154.
Patten BM, Mendell J., Bruun B., Curtin W., Carter S.Double-blind study of the effects of dexamethasone on acute stroke . Neurology1972;22:377-383.
32.
Russek HI, Russek AS, Zohman BLCortisone in immediate therapy of apoplectic stroke. JAMA1955;159:102-105.
33.
Rubenstein MKThe influence of adrenocortical steroids on severe cerebrovascular accidents. J Nervous Mental Dis1965;141:291-299.
34.
Norris JW, Hachinski VCHigh dose steroid treatment in cerebral infarction. Brit Med J1986;292:21-23.
35.
Bauer RB, Tellez H.Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke1973;4:547-555.
36.
Poungvarin N., Bhopat W., Viriyavejakul A., et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. NEJAM1987;316:1229-1233.
37.
Karpiak SE, Li YS, Mahadik SPGangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function. Stroke1987;18:184-187.
38.
Abe K., Yuki S., Kogure K.Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke1988;19:480-485.
39.
Young W., Wojak JC, DeCrescito V. 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke1988;19:1013-1019.
40.
Kirino T.Delayed neuronal death in the gerbil hippocampus following ischemia . Brain Res1982;239:57-69.
41.
Pulsinelli WA, Brierly JB, Plum F.Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol1982;11:491-498.
42.
Ito M., Spatz M., Walker JT, Klatzo I.Experimental cerebral ischemia in Mongolian gerbils. 1. Light microscopic observations. Acta Neuropathol (Berlin ) 1975;32:209-223.
43.
Petito CK, Feldmann E., Pulsinelli WA, Plum F.Delayed hippocampal damage in humans following cardiopulmonary arrest. Neurology1987;37:1281-1286.
44.
Greenamyre JTThe role of glutamate in neurotransmission and in neurologic disease. Arch Neurol1986 ;43:1058-1063.
45.
Rothman SM, Olney JWGlutamate and the pathophysiology of hypoxic-ischemic brain damage . Ann Neurol1986;19:105-111.
46.
Jorgensen MB , Diemer NHSelective neuron loss after cerebral ischemia in the rat: possible role of the neurotransmitter glutamate. Acta Neurol Scand1982;66:536-546.
47.
Benveniste H., Drejer J., Schousboe A., Diemer NHElevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis . J Neurochem1984;43:1369-1374.
48.
Benveniste H., Jorgensen MB, Sandberg M., Christensen T., Hagberg H., Diemer NHIschemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J Cereb Blood Flow Metab1989;9:629-639.
49.
Wieloch T.Neurochemical correlates to selective neuronal vulnerability. Prog Brain Res1985;63:69-85.
50.
Novelli A., Reilly JA, Lysko PG, Henneberry RCGlutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when energy levels are reduced. Brain Res1988;451:205-212.
51.
Globus My-T , Ginsberg MDNon-glutamatergic neurotransmission: role in ischemic brain injury. In: Seylaz J, Sercombe R (eds) Neurotransmission and cerebral function . II. Amsterdam : Elsevier, 1989;467-480.
52.
Rothman SMThe neurotoxicity of excitatory amino acids is produced by passive chloride influx. J Neurosci1985;5: 1483-1489.
53.
Siesjo B.Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab1981;1:155-185.
54.
Kochhar A., ZivinJA, Lyden PD. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol1988;45:148-153.
55.
Gill R., Foster AC, Woodruff GNMK-801 is neuroprotective in gerbils when administered during the post-ischemic period. Neuroscience1988;25:847-855.
56.
Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J.The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol1988;24:543-551.
57.
Steinberg GK , Saleh J., Kunis D.Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia. Neurosci Letters1988;89: 193-197.
58.
Steinberg GK , Saleh J., Kunis D., DeLaPaz R., Zamegar SRProtective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits . Stroke1989;20:1247-1252.
59.
Steinberg GK , George CP, DeLa Paz R, Shibata DK, Gross T. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits . Stroke1988;19:1112-1118.
60.
Choi DWDextrorphan and dextromethorphan attenuate glutamate neurotoxicity . Brain Res1987;403:333-336.
61.
Boast CA, Gerhardt SC, Pastor G., Lehmann JF, Etienne PE, Liebman JMThe N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res1988;442:345-348.
62.
Busto R., Dietrich WD, Globus My-T, Ginsberg MDThe importance of brain temperature in cerebral ischemic injury. Stroke1989;20:1113-1114.
63.
Busto R., Dietrich WD, Globus My-T, Valdes I., Scheinberg P., Ginsberg MDSmall differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab1987;7:729-738.
64.
Busto R., Globus My-T, Dietrich WD, Martinez E., Valdes I., Ginsberg MDEffect of mild hypothermia on ischemia-included relese of neurotransmitters and free fatty acids in rat brain. Stroke1989;20:904-910.
65.
Buchan A., Pulsinelli WAAre the neuroprotective effects of MK-801 mediated by hypothermia?Stroke1989;20:148 (abstr).
66.
Phillis JW, Wu PHThe role of adenosine and its nucleotides in central synaptic transmission . Prog Neurobiol1981;16: 187-239.
67.
Lee KS, Tetzlaff W., Kreutzberg GWRapid down regulation of hippocampal adenosine receptors following brief anoxia . Brain Res1986;380:155-158.
68.
Rudolphi KA , Manfred K., Heinz-Joachim H.Effect of theophylline on ischemically induced hippocampal damage in mongolian gerbil: a behavioral and histopathological study. J Cereb Blood Flow Metab1987;7:74-81.
69.
Daval JL, Von Lubitz DKJE, Deckert J, Redmond DJ, Marangos PJ. Protective effect of cyclobexyladenosine on adenosine A1-receptors, guanine nucleotide and forskolin binding sites following transient brain ischemia: a quantitative autoradiographic study. Brain Res1989;491:212-226.
70.
von Monakow C.Die lokalisation im grosshirn und der abbau der funktion durch kortikale herde. Wiesbaden: J.F. Bergmann, 1914.
Castella Y. , Dietrich WD, Watson BD, Busto R.Acute thrombotic infarction suppresses metabolic activaiton of ipsilateral somatosensory cortex: evidence for functional diaschisis . J Cereb Blood Flow Metab1989;9:329-341.
73.
Robinson RG , Bloom FE, Battenberg Elf.A fluorescent histochemical study of changes in noradrenergic neurons following experiemtal cerebral infarction in the rat. Brain Res1977;132:259-272.
74.
Lenzi GL, Frackowiak Rsj, Jones T.Cerebral oxygen metabolism and blood flow in human cerebral infarction . J Cereb Blood Flow Metab1982;2:321.
75.
Martin Wrw, Raichle MECerebellar blood flow and metabolism in cerebral hemisphere infarction . Ann Neurol1983;14:168-176.
76.
Pappata S., Mazoyer B., Dinh T., Cambon H., Levasseur M., Baron JCEffects of capsular or thalamic stroke on metabolism in the cortex and cerebellum: a positron tomography study. Stroke1990;21:519-524.
77.
Slater R., Reivich M., Goldberg H., Banka R., Greenberg J.Diaschisis with cerebral infarction. Stroke1977;8:684-690.
Feeney DM, Sutton RL, Boyeson MG, Hovda DA, Dail WGThe locus-coeruleus and cerebral metabolism: recovery of function after cortical injury. Physiol Psych1985;13:197-203.
80.
Crisostomo EA, Duncan PW, Propst MA, Dawson DB, Davis JNEvidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients . Ann Neurol1988;23:94-97.
81.
Laurence S., Stein DGRecovery after brain damage and the concept of localization of function . In: Finger S (ed). Recovery from brain damage. research and theory. New York: Plenum Press, 1978 ;369-407.
82.
Rothi LJ, Homer J.Restitution and substitution: two theories of recovery with application to neurobehavioral treatment. J Clin Neuropsych1983;5:73-81.
83.
Wolf SL, Lecraw DE, Barton LA, Jann BBForced use of hemiplegic upper extremities to reverse the effect of learned nonuse among chronic stroke and head-injured patients. Exp Neurol1989; 104:125-132.
84.
Ostendorf CG , Wolf SLEffect of forced use of the upper extremity of a hemiplegic patient on changes in function. Phys Ther1981;61:1022-1028.
85.
Lashley KSBrain mechanisms and intelligence. Chicago: University of Chicago Press, 1929.
86.
Luria ARRestoration of function after brain injury. New York: MacMillian, 1963.
87.
Luria ARHigher cortical functions in man. New York: Basic Books, 1966.
88.
Wall PDMechanisms of plasticity of connection following damage in adult mammalian nervous systems. In: Bach-y-Rita P (ed). Recovery of function: theoretical considerations for brain injury rehabilitation. Baltimore: University Park Press, 1978;91-105.
89.
Dietrich WD , Alonso O., Busto R., Ginsberg MDThe effect of amphetamine on functional brain activation in normal and post-infarcted rat . Stroke1990;21(suppl. IIII):III-147-III-150.
90.
Bliss Tvp, Dolphin ACWhat is the mechanism of long-term potentiation in the hippocampus? . TINS1982;5:289-290.
91.
Bliss Tvp, Lomo T.Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol1973; 232:331-356.
92.
Bliss Tvp, Gardner-Medwin ARLong-lasting potentiation of synaptic transmission in the dentate area of the un-anaesthetized rabbit following stimulation of the perforant path. J Physiol1973;232:357-374.
93.
Collingridge GL, Bliss Tvp.NMDA receptors- their role in long-term potentiation. TINS1987;10:288-293.
94.
Artola A., Singer W.NMDA receptors and developmental plasticity in visual neocortex. In: Collingridge GL, Watkins JC (eds) The NMDA Receptor. Oxford: Oxford University Press, 1989; 153-166.
95.
Swanson LW, Teyler TJ, Thompson RFHippocampal long-term potentiation: Mechanisms and implications for memory . Neurosci Res Prog Bull1982;20:601-769.
96.
Wenk GL, Grey CM, Ingram DK, Spangler EL, Olton DSRetention of maze performance inversely correlates with N-methyl-D-aspartate receptor number in hippocampus and frontal neocortex in the rat. Behav Neurosci1989;103:688-690.
97.
Benvenga MJ , Spaulding TCAmnesic effect of the novel anticonvulsant MK-801. Pharmacol Biochem Behav1989; 30:205-207.
98.
Handelmann GE, Contreras PC, O'Donohue TL. Selective memory impairment by phencyclidine in rats. Eur J Pharmacol1987; 140:69-73.
99.
Morris Rgm, Anderson E., Lynch GS, Baudry M.Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature1986;319:774-776.
100.
Barth TM, Grant ML, Schallert T.Effects of MK-801 on recovery from sensorimotor cortex lesions. Stroke1990; 21(Suppl. III):III-153-III-157.
101.
Goldstein LBPharmacology of recovery after stroke. Stroke1990;21 (Suppl. III):III-139-III-142.
102.
Stanton PK , Sarvey JMBlockade of norepinephrine-induced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis . Brain Res1985; 361:276-283.
103.
Dahl D., Sarvey JMNorepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus. Proc Natl Acad Sci USA1989;86: 4776-4780.
104.
Hopkins WF , Johnston D.Frequency-dependent moradrenergic modulation of long-term potentiation in the hippocampus. Science1984;226:350-352.
105.
Everitt BJ , Robbins TW, Gaskin M.The effects of lesions to ascending noradrenergic neurons on discrimination learning and performance in the rat. Neuroscience1983;10:397-410.
106.
Prado deCarvalho L., Zornetzer SFThe involvement of the locus ceruleus in memory. Behav Neural Biol1981;31:173-186.
107.
Stein L., Beluzzi JD, Wise CDMemory enhancement by central administration of norepinephrine. Brain Res1975; 84:329-335.
108.
Gold PE, Delanoy RL, Merrin J.Modulation of long-term potentiation by peripherally administered amphetamine and epinephrine. Brain Res1984 ;305:103-107.
109.
Altman HJ, Quartermain D.Facilitation of memory retrieval by centrally administered catecholamine stimulating agents. Behav Brain Res1983;7:51-63.
110.
Quartermain D., Botwinick CYRole of the biogenic amines in the reversal of cycloheximide-induced amnesia. J Comp Physiol Psych1975;88:386-401.
111.
Feeney DM, Gonzalez A., Law WAAmphetamine haloperidol and experience interact to affect the rate of recovery after motor cortex injury. Science1982;217:855-857.
112.
Feeney DM, Gonzalez A., Law WAAmphetamine restores locomotor function after motor cortex injury in the rat . Proc West Pharmacol Soc1981;24:15-17.
113.
Goldstein LBAmphetamine-facilitated functional recovery after stroke. In: Ginsberg MD, Dietrich WD (eds) Cerebrovascular diseases. Sixteenth research (Princeton) conference. New York: Raven Press , 1988;303-308.
114.
Goldstein LB, Davis JNInfluence of lesion size and location on amphetamine-facilitated recovery of beam-walking in rats. Behav Neurosci1990;104:318-325.
115.
Goldstein LB, Davis JNPost-lesion practice and amphetamine-facilitated recovery of beam-walking in the rat. RestorativeNeurol Neurosci1990;1:311-314.
116.
Salo AA, Feeney DMReduction of morbidity, mortality, and lesion size in a rat model of cerebral infarction with amphetamine, Soc Neurosci Abstr1987;13:1268 (abstr.).
117.
Boyeson MG , Feeney DMThe role of norepinephrine in recovery from brain injury. Soc Neurosci Abstr1984 ;10:68 (abstr.).
118.
Hovda DA, Feeney DMAmphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res1984;298:358-361.
119.
Sutton RL, Hovda DA, Feeney DMAmphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. BehavNeurosci1989;103: 837-841.
120.
Feeney DM, Hovda DAAmphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology1983 ;79:67-71.
121.
Hovda DA, Feeney DMHaloperidol blocks amphetamine induced recovery of binocular depth perception after bilateral visual cortex ablation in the cat. Proc West Pharmacol Soc1985;28:209-211.
122.
Feeney DM, Hovda DAReinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res1985 ;342:352-356.
123.
Hovda DA, Sutton RL, Feeney DMAmphetamine-induced recovery of visual cliff performance after bilateral visual cortex ablation in cats: measurements of depth perception thresholds . Behav Neurosci1989;103:574-584.
124.
Fuxe K., Ungerstedt U.Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration. In: Costa E, Garattini S (eds) Amphetamines and related compounds. New York : Raven Press, 1970;257-288.
125.
Davis JN, Arnett CD, Hoyler E., Stalvey LP, Daly JW, Skolnick P.Brain alpha-adrenergioc receptors: comparison of [3H]WB4101 binding with norepinephrine-simulatedcyclic AMP accumulation in rat cerebral cortex . Brain Res1978;159:125-135.
126.
Boyeson MG, Krobert KA, Hughes JMNorepinephrine infusions into cerebellum facilitate recovery from sensorimotor cortex injury in the rat. Soc Neurosci Abstr1986; 12:1120 (abstr.).
127.
Boyeson MG, Feeney DMIntraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol Biochem Behav1990 ;35:497-501.
128.
Krobert KA, Boyeson MG, SchererPJ. The role of the locus ceruleus in recovery of function from sensorimotor cortex injury. Soc Neurosci Abstr1987;13:1664 (abstr.).
129.
Weaver MS, Chen MJ, Westerberg VS, Feeney DMLocus coeruleus lesions facilitate recovery of locomotor function after sensorimotor cortex contusion in the rat. Soc Neurosci Abstr1988; 14:405 (abstr.).
130.
Weaver MS, Farmer LJ, Feeney DMNorepinephrine agonists and antagonists influence rate and maintenance of recovery of function after sensorimotor cortex contusion in the rat. Soc Neurosci Abstr1987;13:477 (abstr.).
131.
Sutton RL, Feeney DMYohimbine accelerates recovery and clonidine and prazosin reinstate deficits after recovery in rats with sensorimotor cortex ablation. Soc Neurosci Abstr1987;13:913 (abstr.).
132.
Goldstein LB, Poe HV, Davis JNAn animal model of recovery of function after stroke: facilitation of recovery by an alpha2-adrenergic receptor antagonist . Ann Neurol1989; 26:157 (abstr.).
133.
Stephens J. , Goldberg G., Demopoulos JTClonidine reinstates deficits following recovery from sensorimotor cortex lesion in rats. Arch Phys Med Rehabil1986;67:666-667.
134.
Goldstein LB, Davis JNClonidine impairs recovery of beam-walking in rats. Brain Res1990;508:305-309.
135.
Douglas RM , Goddard GV, Riives M.Inhibitory modulation of long-term potentiation: evidence for a postsynaptic locus of control. Brain Res1982;240:259-272.
136.
Douglas RM , McNaughton BL, Goddard GVCommissural inhibition and facilitation of granule cell discharge in fascia dentata. J Comp Neurol1983;219:285-294.
137.
Riches IP, Brown MWThe effect of lorazepam upon hippocampal long-term potentiation. Neurosci Letters1986;S42-S40.
138.
Satoh M., Ishihara K., Iwama T., Takagi H.Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices. Neurosci Letters1986;68:216-220.
139.
Lister R.The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev1985;9:87-93.
140.
Roth T., Roehrs T., Wittig R., Zorick F.Benzodiazepine and memory. Br J Clin Pharmacol1984;18(Suppl.):45S-49S.
141.
Wigstrom H. , Gustafsson B.Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiol Scand1985 ;125:159-172.
142.
Lal H., Kumar B., Forster MJEnhancement of learning and memory in mice by a benzodiazepine antagonist . FASEB J1988;2:2707-2711.
143.
Brailowsky S., Knight RT, Efron R.Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res1986; 376:71-77.
144.
Chwch AY, Swinyard EA, Wolf HHInvolvement of a GABAergic mechanism in the pharmacologic action of phenytoin . Pharmacol Biochem Behav1986;24:1301-1304.
145.
Schallert T., Hernandez TD, BarthTM. Recovery offunction after brain damage: severe and chronic disruption by diazepam. Brain Res1986;379:104-111.
146.
Hernandez TD, Jones TA, Schallert T.The role of GABA in recovery of function after cortical lesions. Soc Neurosci Abstr1988;14:844 (abstr.).
147.
Cheney DL, LeFevre HF, Racagni G.Choline acetyltransferase activity and mass fragmentographic measurement of acetylcholine in specific nuclei and tracts of rat brain. Neuropharmacology1975;14:801-809.
148.
KuharMJ,AtwehSF, Bird SJ. Studies of cholinergic-monoaminergic interactions in rat brain. In: Butcher LL (ed). Cholinergic-monoaminergic interaction in the brain . New York: Academic Press, 1978;211.
149.
Sibley DR, Lefkowitz RJMolecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature1985; 317:124-129.
150.
Wagner HR, Davis JNBeta-adrenergic receptor regulation by agonists and membrane depolarization in rat brain slices. Proc Natl Acad Sci USA1979;76:2057-2061.
151.
Geinisman Y., Morrell F, DeToledo-Morrell L. Perforated synapses on double-headed dendritic spines: a possible structural substrate of synaptic plasticity. Brain Res1989; 480:326-329.
Walsh RNEffects of environmental complexity and deprivation on brain anatomy and histology: a review. InternJ Neuroscience1981;12:33-51.
154.
Bailey CH, Chen M.Structural plasticity at identified synapses during long- term memory in Aplysia . J Neurobiol1989;20:356-372.
155.
Goldstein LB, Matchar DB, Morgenlander JC, Davis JNDrugs influence the recovery of function after stroke. Stroke1990;21:179 (abstr.).
156.
Porch B., Wyckes J., Feeney DMHaloperidol, thiazides, and some antihypertensives slow recovery from aphasia . Soc Neurosci Abstr1985;11:52 (abstr.).
157.
Finger S., Stein DGBrain damage and recovery. New York: Academic Press, 1982.
158.
Davis JNNeuronal rearangements after brain injury: A proposed classification . In: Becker DP, Povlishock JT (eds) NIH central nervous system trauma status report. Washington, DC: National Institutes of Health, 1985;491-501.
159.
Cotman CW, Nieto-Sampedro M., Harris EWSynapse replacement in the nervous system of adult verebrates. Physiol Rev1981;61:684-784.
160.
Lund RDDevelopment and plasticily of the brain. New York : Oxford Univ Press1978.
161.
Bernstein DR, Stelzner DJPlasticity of the corticospinal tract following midthoracic spinal injury in the postnatal rat. J Comp Neurol1983;221:382-400.
162.
Foerster APSpontaneous regeneration of cut axons in adult rat brain. J Comp Neurol1982;210:335-356.
163.
Schneider GE, Jhaveri SRNeuroanatomical correlates of spared or altered function after brain lesion in newborn hamster. In: Becker DP, Povlishock JT (eds) Plasticity and recovery of function in the central nervous sysytem. New York: Academic Press, 1974;65-109.
164.
Haring JH, Miller GD, Davis JNChanges in noradrenergic innervation of the Area Dentata after axotomy of coerulohippocampal projections or unilateral lesion of the locus coeruleus . Brain Res1986;368:233-238.
165.
Haring JH, Davis JNRetrograde labeling of locus coeruleus neurons after lesion induced sprouting of coeruleohippocampal projection. Brain Res1985;360:384-388.
166.
Gage FH, Bjorklund A., Stenevi U., Dunnett SBFunctional correlates of compensatory collateral sprouting by aminergic and cholinergic afferents in hippocampal formation. Brain Res1983;268:39-47.
167.
Gage FH, Bjorklund A., Stenevi U.Reinnervation of partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents. Brain Res1983 ;268:27-37.
168.
Pickel VM, Krebs H., Bloom FEProliferation of norepinephrine-containing axons in rat cerebellar cortex after peduncle lesions. Brain Res1973 ;59:169-179.
169.
Gage FH, Bjorklund A., Stenevi U.Local regulation of compensatory noradrenergic hyperactivity in the partially denervated hippocampus. Nature1983 ;819:819-821.
170.
Steward O. , Cotman CW, Lynch GSRe-establishment of electrophysiologically functional entorhinal cortical input to the dentate gyrus deafferented by ipsilateral entorhinal lesions: innervation by the contralateral entorhinal cortex. Exp Brain Res1973;18:396-414.
171.
Tsukahara N., Hultborn H., Murakami F., Fujito Y.Electrophysiological study of formation of new synapses and collateral sprouting in red nucleus neurons after partial denervation. J Neurophysiol1975;38:1359-1372.
172.
Crutcher KASympathetic sprouting in the central nervous system: a model for studies of axonal growth in the mature mammalian brain . Brain Res Rev1987;12:203-233.
173.
Harrell LE , Barlow TS, Davis JNSympathetic sprouting and recovery of spatial behavior. Exp Neurol1983;82:379-390.
174.
Harrell LE , Parsons DSThe role of sympathetic ingrowth in the behavioral effects of nucleus basalis magnocellularis lesions. Brain Res1988;474:353-358.
175.
Battistin L., Cesari A., Galligioni F., et al. Effects of GM1 ganglioside in cerebrovascular diseases: A double-blind trial in 40 cases . Eur Neurol1985;24:343-351.
176.
Bassi S., Albizzati MG, Sbacchi M., Frattola L., Massarotti M.Double-blind evaluation of monosialoganglioside (GM 1) therapy in stroke. J Neurosci Res1984;12:493-498.
177.
Argentino C., Sacchetti ML, Toni D., et al. GM1 ganglioside therapy in acute ischemic stroke. Stroke1989 ;20:1143-1149.
178.
Hoffbrand BI, Bingley PJ, Oppenheimer SM, Sheldon CDTrial of GM1 in acute stroke. J Neurol Neurosurg Psychiatry1988;51:1213-1214.
179.
Asplund K.Clinimetrics in stroke research. Stroke1987; 18:528-530.
180.
Cote R., Battista RN, Wolfson C., Boucher J., Adams J., Hachinski VCThe Canadian Neurological Scale: validation and reliability assessment . Neurology1989;39:638-643.
181.
Goldstein LB, Bertels C., Davis JNInterrater reliability of the N.I.H. stroke scale. Arch Neurol1989 ;46:660-662.
182.
Brott T., Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke1989;20:864-870.
183.
Lincoln NB , Blackburn M., Ellis S., et al. An investigation of factors affecting progress of patients on a stroke unit. J Neurol Neurosurg Psychiatry1989;52:493-496.
184.
Duncan PW, Propst MA, Nelson SGReliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. J Amer Phys Ther Assn1983; 63:1606-1610.
185.
Fugl-Meyer AR, Jaasko L., Leyman I., Olsson S., Steglind S.The post-stroke hemiplegic patient. I. A method for evaluation of physical performance. Scand J Rehab Med1975;7: 13-31.
186.
Goldstein LB, Matchar DB, Morgenlander JC, Davis JNThe influence of drugs on the recovery of sersorimotor function after stroke. J Neuro Rehab1991: in press.
187.
Porch BE, Feeney DMEffects of antihypertensive drugs on recovery from aphasia. Clin Aphasiology1986;16:309-314.